MVMD

Mountain Valley MD Holdings Inc.

Mountain Valley MD Proceeding With COVID-19 Clearance Trial in Level 4 Biohazard Facility

TORONTO, Jan. 27, 2021 - Mountain Valley MD Holdings Inc. (the "Company" or "MVMD") (CSE: MVMD) (FRA: 20MP) is pleased to announce it has executed an agreement to conduct its Bio Safety Level 4 ("BSL-4") lab study of COVID-19 viral clearance in transgenic mice designed to prove the superiority of the Company's solubilized Ivermectin techn... Read More...

Mountain Valley MD Holdings Announces Application for OTCQB Listing in U.S., Provides Update on Warrant Exercises

TORONTO, Jan. 11, 2021 - Mountain Valley MD Holdings Inc. (the "Company" or "MVMD") (CSE: MVMD) (FRA: 20MP) is pleased to announce that it has submitted an application to have its common shares listed for trading on the OTCQB market (the "OTCQB"), a U.S. trading platform that is operated by the OTC Markets Group in New York. The listing o... Read More...

Mountain Valley MD Completes Strategic Sale of Subsidiary, Finalizing Quicksome™ License Agreement

VANCOUVER, BC, Dec. 29, 2020 - Mountain Valley MD Holdings Inc. (the "Company" or "MVMD") (CSE: MVMD) (FRA: 20MP) is pleased to announce that Mountain Valley MD Inc. ("Mountain Valley") has completed the first portion of a multi-prong strategic agreement with Circadian Wellness Corp. ("Circadian"), a privately held Ontario corporation tha... Read More...